Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health, Inc. (NYSE: ELV) generates a steady stream of news as a major participant in the direct health and medical insurance carriers industry. Company updates frequently focus on financial performance, member experience initiatives, digital tools, and community health programs. Investors and observers following ELV news can see how Elevance Health communicates its strategy as a lifetime, trusted health partner serving over 109 million consumers through medical, pharmacy, behavioral, clinical, home health, and complex care solutions.
News coverage often includes earnings results and guidance, such as quarterly financial releases that detail segment performance for Health Benefits and Carelon, membership trends across commercial, Medicare, Medicaid, and Federal Employee Program lines, and commentary on benefit expense ratios and operating metrics. The company also issues announcements about upcoming conference calls and webcasts where management reviews results and outlook with investors.
Another key theme in Elevance Health news is the evolution of the healthcare consumer experience. Articles describe AI-enabled digital solutions, including the Virtual Assistant available through the Sydney Health app, which helps members understand benefits, compare costs, and find in-network providers. The company also highlights care management programs, concierge-style support for serious illnesses, and models such as “My Health Advocate” in affiliated Medicare plans.
Elevance Health news frequently covers whole-health and community initiatives. Examples include Food as Medicine partnerships with the National Association of Community Health Centers, school-based fitness facility upgrades, and expanded access to doula care and social supports in certain Medicare Advantage and Medicaid plans. Governance developments, such as the appointment of independent directors to the board and related committee assignments, are also reported through press releases and SEC-linked announcements.
By reviewing the ELV news feed on this page, readers can follow financial disclosures, strategic initiatives, digital and clinical innovations, and community-focused programs that shape Elevance Health’s role in the health benefits and healthcare services landscape.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Elevance Health reported robust first-quarter results for 2023, with a GAAP net income of $8.30 per share, including negative adjustments of $1.16 per share. Adjusted net income reached $9.46 per share. Operating revenue grew by 10.6% year-over-year to $41.9 billion, driven by an increase in medical membership to 48.1 million, up by 1.3 million members. The company declared a second-quarter dividend of $1.48 per share. Operating cash flow improved to approximately $6.5 billion, bolstered by early premium payments. Notably, operating gain also increased by 16.6% to $2.8 billion. The company anticipates GAAP net income exceeding $29.50 per share for the year.
Elevance Health (NYSE: ELV) will announce its first quarter 2023 financial results on April 19, 2023, at 6:00 a.m. EDT. A conference call to discuss these results and the company's outlook will follow at 8:30 a.m. EDT. Interested parties should dial in at least 15 minutes prior to the call using the provided numbers, including 888-947-9963 for domestic access. The call will also be available via webcast, and a replay can be accessed from 11:30 a.m. EDT on the same day until the end of May 19, 2023.
Elevance Health is dedicated to enhancing health outcomes, serving approximately 119 million people through a comprehensive range of healthcare solutions.